SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/24BC0E2E04D564A28D30E1AD136EC9FF4E5355CFB03C7CF2ACAD9E90F5D36BDBA4293F303CF947A78306FEDD304759C7>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/24BC0E2E04D564A28D30E1AD136EC9FF4E5355CFB03C7CF2ACAD9E90F5D36BDBA4293F303CF947A78306FEDD304759C7
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/24BC0E2E04D564A28D30E1AD136EC9FF4E5355CFB03C7CF2ACAD9E90F5D36BDBA4293F303CF947A78306FEDD304759C7
http://www.w3.org/2000/01/rdf-schema#comment
"These results indicated that CXCL10 inhibited LNCaP cell proliferation and decreased PSA production by up-regulation of CXCR3 receptor. CXCL10 may be potentially useful in the treatment of prostate cancer."
xsd:string
http://purl.uniprot.org/uniprot/#_1E8983A3E5F6E437070584D4B5B033953172ECDC332EC988797258177D4D4966DE2A0AC6CB4F123BF77070A359A1080F
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/24BC0E2E04D564A28D30E1AD136EC9FF4E5355CFB03C7CF2ACAD9E90F5D36BDBA4293F303CF947A78306FEDD304759C7
http://purl.uniprot.org/uniprot/P49682
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/24BC0E2E04D564A28D30E1AD136EC9FF4E5355CFB03C7CF2ACAD9E90F5D36BDBA4293F303CF947A78306FEDD304759C7
http://purl.uniprot.org/uniprot/#_P49682-mappedCitation-16934957
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/24BC0E2E04D564A28D30E1AD136EC9FF4E5355CFB03C7CF2ACAD9E90F5D36BDBA4293F303CF947A78306FEDD304759C7